DNA Probes and Biochips

reuters – 10/30/09

Research and Markets: Molecular Diagnostics Market: DNA Probes and Biochips – New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers

DUBLIN–(Business Wire)– Research and Markets (http://www.researchandmarkets.com/research/64550c/molecular_diagnost) has announced the addition of the “Molecular Diagnostics Market: DNA Probes and Biochips — New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers” report to their offering.

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next ten years will witness significant developments in reagent systems and automation, as well as the introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems which will utilize amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new DNA probe and biochip technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next ten years.

This comprehensive worldwide study is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the molecular diagnostics market during the next decade. The study explores business and technological trends in major markets; provides 5-and 10-year test volume and sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next ten years.

Contains 1,050 pages and 96 tables * INTRODUCTION * WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW * MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES * DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS * ALTERNATIVE MARKET PENETRATION STRATEGIES * POTENTIAL MARKET ENTRY BARRIERS AND RISKS

SOME COMPETITIVE PROFILES * Abbott * Aclara * Affymetrix * Agilent * Ambion * Applied Biosystem * ARCA Biopharma * Beckman Coulter * BD * Biokit * BioMerieux * Biotest * Caliper * Cepheid * Chiron

For more information visit http://www.researchandmarkets.com/research/64550c/molecular_diagnost Research and Markets Laura Wood, Senior Manager U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 press@researchandmarkets.com Copyright Business Wire 2009

DNAWellnessinfo.com Resource:  http://www.reuters.com/article/pressRelease/idUS182722+30-Oct-2009+BW20091030